News

Learn about Leqembi, Saudi Arabia's first approved treatment for Alzheimer’s disease, marking a major advancement in ...
The FDA cleared the use of the first approved blood test that can help diagnose Alzheimer’s disease. Learn more from U of U ...
Dementia can feel like a scary word but knowing what it means and how to spot the signs early can make a big difference.
Researchers at the Carney Institute for Brain Science have identified electrical activity in the brain that could predict ...
Blarcasemine met its primary endpoints, improving cognition and function over a four year period in early-stage Alzheimer’s patients.
Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...
Eli Lilly’s Alzheimer’s disease (AD) drug donanemab has been recommended by the European Medicines Agency’s human medicines ...
Kisunla, a newly approved Alzheimer's drug in Taiwan, would not be covered by the National Health Insurance (NHI) system, ...
At just 29, Melbourne mum Erin Kelly is facing the heartbreaking reality that she's living on borrowed time. A single parent ...
A gene-matched Alzheimer’s drug that slows early symptoms is now approved for use. Patients will need genetic screening, fortnightly infusions, and regular brain scans to stay on treatment.
More than 64,000 people in Ireland currently suffer from dementia — and this figure is predicted to more than double over the ...